479 related articles for article (PubMed ID: 6110915)
1. Calcitonin and the calcium-regulating hormones in postmenopausal women: effect of oestrogens.
Stevenson JC; Abeyasekera G; Hillyard CJ; Phang KG; MacIntyre I; Campbell S; Townsend PT; Young O; Whitehead MI
Lancet; 1981 Mar; 1(8222):693-5. PubMed ID: 6110915
[TBL] [Abstract][Full Text] [Related]
2. Effects in postmenopausal women of natural and synthetic estrogens on calcitonin and calcium-regulating hormone secretion. Relevance to postmenopausal osteoporosis.
Whitehead MI; Lane G; Townsend PT; Abeyasekera G; Hillyard CJ; Stevenson JC
Acta Obstet Gynecol Scand Suppl; 1981; 106():27-32. PubMed ID: 6951874
[TBL] [Abstract][Full Text] [Related]
3. Regulation of calcitonin and parathyroid hormone secretion by oestrogens.
Stevenson JC
Maturitas; 1982 Apr; 4(1):1-7. PubMed ID: 6896553
[TBL] [Abstract][Full Text] [Related]
4. Regulation of calcium-regulating hormones by exogenous sex steroids in early postmenopause.
Stevenson JC; Abeyasekera G; Hillyard CJ; Phang KG; MacIntyre I; Campbell S; Lane G; Townsend PT; Young O; Whitehead MI
Eur J Clin Invest; 1983 Dec; 13(6):481-7. PubMed ID: 6315447
[TBL] [Abstract][Full Text] [Related]
5. Prospective trial of oestrogen and calcium in postmenopausal women.
Horsman A; Gallagher JC; Simpson M; Nordin BE
Br Med J; 1977 Sep; 2(6090):789-92. PubMed ID: 912324
[TBL] [Abstract][Full Text] [Related]
6. Calcitonin, estrogens and the bone.
Gennari C; Agnusdei D
J Steroid Biochem Mol Biol; 1990 Nov; 37(3):451-5. PubMed ID: 2257249
[TBL] [Abstract][Full Text] [Related]
7. [Sex hormone replacement following menopause--for all women? A plea for prevention using estrogens and gestagens].
Nocke W
Ther Umsch; 1995 Oct; 52(10):693-704. PubMed ID: 7482382
[TBL] [Abstract][Full Text] [Related]
8. Postmenopausal and senile osteoporosis: current concepts of etiology and treatment.
Riggs BL
Endocrinol Jpn; 1979 Jun; 26(Suppl):31-41. PubMed ID: 467347
[TBL] [Abstract][Full Text] [Related]
9. [Postmenopausal bone loss. Role of estrogens].
Trémollières F; Pouilles JM; Ribot C
Presse Med; 1992 May; 21(19):903-6. PubMed ID: 1386433
[TBL] [Abstract][Full Text] [Related]
10. Bone loss during oestriol therapy in postmenopausal women.
Lindsay R; Hart DM; Maclean A; Garwood J; Clark AC; Kraszewski A
Maturitas; 1979 Jun; 1(4):279-85. PubMed ID: 399316
[TBL] [Abstract][Full Text] [Related]
11. Effects of one-year treatment with estrogens on bone mass, intestinal calcium absorption, and 25-hydroxyvitamin D-1 alpha-hydroxylase reserve in postmenopausal osteoporosis.
Civitelli R; Agnusdei D; Nardi P; Zacchei F; Avioli LV; Gennari C
Calcif Tissue Int; 1988 Feb; 42(2):77-86. PubMed ID: 3127028
[TBL] [Abstract][Full Text] [Related]
12. Deficient calcitonin response to calcium stimulation in postmenopausal osteoporosis?
Taggart HM; Chesnut CH; Ivey JL; Baylink DJ; Sisom K; Huber MB; Roos BA
Lancet; 1982 Feb; 1(8270):475-8. PubMed ID: 6121141
[TBL] [Abstract][Full Text] [Related]
13. A unitary model for involutional osteoporosis: estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men.
Riggs BL; Khosla S; Melton LJ
J Bone Miner Res; 1998 May; 13(5):763-73. PubMed ID: 9610739
[TBL] [Abstract][Full Text] [Related]
14. Relative deficiency of plasma-calcitonin in normal women.
Hillyard CJ; Stevenson JC; MacIntyre I
Lancet; 1978 May; 1(8071):961-2. PubMed ID: 76891
[TBL] [Abstract][Full Text] [Related]
15. [Changes in bone mineral content and bone metabolism related to menopause].
Ohta H; Nemoto K; Nozawa S; Iizuka R
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Sep; 41(9):1447-54. PubMed ID: 2584821
[TBL] [Abstract][Full Text] [Related]
16. [Current research in therapy of postmenopausal osteoporosis (author's transl)].
Laroche C; Detilleux M; Sereni D
Sem Hop; 1979 Feb 18-25; 55(7-8):325-9. PubMed ID: 220722
[TBL] [Abstract][Full Text] [Related]
17. The effect of transdermal oestrogen on bone, calcium-regulating hormones and liver in postmenopausal women.
Selby PL; Peacock M
Clin Endocrinol (Oxf); 1986 Nov; 25(5):543-7. PubMed ID: 3113780
[TBL] [Abstract][Full Text] [Related]
18. Prevention of bone loss by hormone replacement therapy is probably not due to stimulation of calcitonin secretion.
Fletcher CD; Farish E; Leggate J; Hart DM
Acta Endocrinol (Copenh); 1991 Apr; 124(4):353-6. PubMed ID: 2031433
[TBL] [Abstract][Full Text] [Related]
19. [Pharmacologic therapy of osteoporosis].
Kushida K
Nihon Rinsho; 1994 Sep; 52(9):2367-77. PubMed ID: 7967083
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance and pathogenesis of osteoporosis.
Nordin BE
Br Med J; 1971 Mar; 1(5749):571-6. PubMed ID: 5548297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
